CONMED announces significant changes to its Chief Financial Officer (CFO) position

John E. Gallagher will succeed Todd Garner as the company's new Chief Financial Officer. Meanwhile, Todd Garner will not immediately leave the company; he will continue to serve as an advisor, providing guidance on the company's financial affairs. This advisory role will last until November 2, 2026.This personnel change marks a smooth transition within CONMED's financial management team. The company aims to ensure a seamless transfer of financial leadership responsibilities, while also making full use of the outgoing CFO’s extensive experience and knowledge. By establishing the transitional advisory role, the company expects to maintain strategic continuity in its finances and provide necessary support to the new CFO.This arrangement demonstrates the company’s forward-thinking approach to governance. It achieves a successful handover in key positions while retaining the expertise of senior executives to help the company face future financial challenges and opportunities.